Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

R Christensen, PK Kristensen, EM Bartels, H Bliddal… - The Lancet, 2007 - thelancet.com
Background Since the prevalence of obesity continues to increase, there is a demand for
effective and safe anti-obesity agents that can produce and maintain weight loss and …

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.

R Christensen, PK Kristensen, EM Bartels… - Lancet (London …, 2007 - europepmc.org
Background Since the prevalence of obesity continues to increase, there is a demand for
effective and safe anti-obesity agents that can produce and maintain weight loss and …

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

R Christensen, PK Kristensen… - Lancet (London …, 2007 - pubmed.ncbi.nlm.nih.gov
Background Since the prevalence of obesity continues to increase, there is a demand for
effective and safe anti-obesity agents that can produce and maintain weight loss and …

[HTML][HTML] Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

R Christensen, PK Kristensen, EM Bartels… - Database of Abstracts …, 2007 - ncbi.nlm.nih.gov
This review concluded that, although rimonabant produced greater weight loss after 1 year
than placebo, it increased the risk of psychiatric adverse events (mood disorders and …

[PDF][PDF] Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

R Christensen, PK Kristensen, EM Bartels, H Bliddal… - Lancet, 2007 - academia.edu
Background Since the prevalence of obesity continues to increase, there is a demand for
effective and safe anti-obesity agents that can produce and maintain weight loss and …

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

R Christensen, PK Kristensen, EM Bartels, H Bliddal… - The Lancet, 2007 - Elsevier
BACKGROUND: Since the prevalence of obesity continues to increase, there is a demand
for effective and safe anti-obesity agents that can produce and maintain weight loss and …

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

R Christensen, PK Kristensen, EM Bartels, H Bliddal… - The Lancet, 2007 - thelancet.com
Background Since the prevalence of obesity continues to increase, there is a demand for
effective and safe anti-obesity agents that can produce and maintain weight loss and …

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

R Christensen, PK Kristensen, EM Bartels… - …, 2007 - portal.findresearcher.sdu.dk
BACKGROUND: Since the prevalence of obesity continues to increase, there is a demand
for effective and safe anti-obesity agents that can produce and maintain weight loss and …

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

R Christensen, PK Kristensen… - …, 2007 - findresearchersdu.elsevierpure.com
BACKGROUND: Since the prevalence of obesity continues to increase, there is a demand
for effective and safe anti-obesity agents that can produce and maintain weight loss and …

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

R Christensen, PK Kristensen, EM Bartels, H Bliddal… - The Lancet, 2007 - infona.pl
Since the prevalence of obesity continues to increase, there is a demand for effective and
safe anti-obesity agents that can produce and maintain weight loss and improve …